Research efforts at the University of California, Los Angeles, supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), are paving the way for breakthroughs in restoring complex movement in individuals facing paralysis. A planned clinical trial, slated to begin recruitment, aims to test new algorithms designed to drive neurorehabilitation strategies using healthy participants as proxies for the data collection phase.
In this article:
- What changed?
- How the study works
- Why is this important?
- FAQ
- Conclusion
- Disclaimer
- Announcement information
What changed?
The upcoming clinical trial marks a significant step in the algorithm development process for neurorehabilitation. While the study is not yet recruiting, it aims to investigate the use of non-invasive activity recording technologies to refine methodologies that could later be used on individuals with paralysis. The target audience includes regulatory professionals, clinical experts, and quality assurance teams monitoring advancements in neurorehabilitation technology.
How the study works
What are the interventions?
Participants will perform experimental tasks while their activity is recorded using non-invasive approaches such as electroencephalography (EEG), electromyography (EMG), inertial measurement units (IMUs), functional near-infrared spectroscopy (fNIRS), eye gaze tracking, or pupillometry. These tools are intended to collect high-quality data while ensuring participant safety.
Who are the sponsors?
This initiative is sponsored by the University of California, Los Angeles, alongside support from NICHD. Such sponsorship reflects an ongoing commitment to developing scientifically rigorous methods for movement disorder rehabilitation.
Why is this important?
The study seeks to bridge the gap between technology development and clinical application. By using healthy participants initially, researchers aim to generate baseline data that informs the eventual adaptation of these algorithms for patients experiencing paralysis. The reliance on multiple non-invasive technologies offers a comprehensive approach to understanding movement-related biomarkers.
The findings could help accelerate innovations in neurorehabilitation devices, potentially influencing regulatory pathways and device design standards for manufacturers seeking approval under MDR Annex XIV or similar frameworks.
FAQ
1. What stage is the study currently in?
The study is in its preliminary phase and not yet recruiting participants.
2. Are the methods invasive?
No, all activity recording methods are non-invasive and prioritize participant comfort and safety.
3. Who can learn from this?
Clinical teams, device manufacturers, and those involved in regulatory affairs can gain insights from the developing technologies and methodologies.
Conclusion
This upcoming clinical trial has the potential to redefine how movement disorders are addressed through algorithmic advancements and device innovations. Stakeholders in regulatory and clinical sectors should follow updates closely, as progress in this study is likely to shape future industry standards and practices.
Disclaimer
This article is for informational purposes only and should not be considered legal or professional regulatory advice. Always consult qualified professionals for guidance tailored to your specific context.
Announcement information
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07236892?term=medical+device